Search

Search bills, members, committees and pages...

CLEARMIND MEDICINE, INC

6 federal lobbying filings, 2025 to 2026.

CLEARMIND MEDICINE, INC is a client on 6 federal lobbying filings, 2025 to 2026, reporting $60K across them. Developer of Psychedelics Medicines Based in British Columbia.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 it has hired, by filings.

RegistrantFilingsReported
RK STRATEGIES, INC.6$60K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$30K
20254$30K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
DEFDefense6
HCRHealth Issues6
VETVeterans6
ALCAlcohol and Drug Abuse5

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 2623Innovative Therapies Centers of Excellence Act of 20254
H.R. 7091Expanding Veterans’ Access to Emerging Treatments Act3
H.R. 3838Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fisc…2
H.R. 8800National Defense Authorization Act for Fiscal Year 20271
H.R. 9237Take Care of America’s Veterans Act1
H.R. 9260Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 20271

Lobbyists

Named on the filings.

LobbyistClientsFilings
RYAN KANE16

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
CLEARMIND MEDICINE, INCRK STRATEGIES, INC.2026 second_quarter$20KJul 18, 2026
CLEARMIND MEDICINE, INCRK STRATEGIES, INC.2026 first_quarter$10KApr 20, 2026
CLEARMIND MEDICINE, INCRK STRATEGIES, INC.2025 fourth_quarter$10KJan 21, 2026
CLEARMIND MEDICINE, INCRK STRATEGIES, INC.2025 third_quarter$10KOct 20, 2025
CLEARMIND MEDICINE, INCRK STRATEGIES, INC.2025 second_quarter$10KJul 21, 2025
CLEARMIND MEDICINE, INCRK STRATEGIES, INC.2025 second_quarterJul 16, 2025